Aditya P. Mohanty - Net Worth and Insider Trading

Aditya P. Mohanty Net Worth

The estimated net worth of Aditya P. Mohanty is at least $108,532 dollars as of 2024-05-08. Aditya P. Mohanty is the Co-CEO of Lineage Cell Therapeutics Inc and owns about 89,696 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $108,532. Details can be seen in Aditya P. Mohanty's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Aditya P. Mohanty has not made any transactions after 2017-08-21 and currently still holds the listed stock(s).

Transaction Summary of Aditya P. Mohanty

To

Aditya P. Mohanty Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aditya P. Mohanty owns 4 companies in total, including OncoCyte Corp (OCX) , Lineage Cell Therapeutics Inc (LCTX) , and Asterias Biotherapeutics Inc (AST) among others .

Click here to see the complete history of Aditya P. Mohanty’s form 4 insider trades.

Insider Ownership Summary of Aditya P. Mohanty

Ticker Comapny Transaction Date Type of Owner
OCX OncoCyte Corp 2015-12-30 director
LCTX Lineage Cell Therapeutics Inc 2017-08-21 Chief Operating Officer
AST Asterias Biotherapeutics Inc 2016-06-09 director
2021-11-08 director & Chief Executive Officer

Aditya P. Mohanty Latest Holdings Summary

Aditya P. Mohanty currently owns a total of 1 stock. Aditya P. Mohanty owns 89,696 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 21, 2017, with a value of $108,532.

Latest Holdings of Aditya P. Mohanty

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LCTX Lineage Cell Therapeutics Inc 2017-08-21 89,696 1.21 108,532

Holding Weightings of Aditya P. Mohanty


Aditya P. Mohanty Form 4 Trading Tracker

According to the SEC Form 4 filings, Aditya P. Mohanty has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 7,500 shares on August 21, 2017, which cost Aditya P. Mohanty around $18,750.

Insider Trading History of Aditya P. Mohanty

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aditya P. Mohanty Trading Performance

GuruFocus tracks the stock performance after each of Aditya P. Mohanty's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aditya P. Mohanty is 1.27%. GuruFocus also compares Aditya P. Mohanty's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aditya P. Mohanty within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Aditya P. Mohanty's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Aditya P. Mohanty

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.75
Relative Return to S&P 500(%) 6.78

Aditya P. Mohanty Ownership Network

Ownership Network List of Aditya P. Mohanty

No Data

Ownership Network Relation of Aditya P. Mohanty


Aditya P. Mohanty Owned Company Details

What does OncoCyte Corp do?

Who are the key executives at OncoCyte Corp?

Aditya P. Mohanty is the director of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .

OncoCyte Corp (OCX) Insider Trades Summary

Over the past 18 months, Aditya P. Mohanty made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 29,247,638 shares made by Broadwood Partners Lp , a net purchase of 283,898 shares made by Andrew Arno , and a net purchase of 55,000 shares made by Alfred D Kingsley .

In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 2,457,288 shares, with a net purchase of 2,457,288 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,850,820 shares were bought by its insiders, resulting in a net purchase of 3,850,820 shares.

OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OncoCyte Corp Insider Transactions

No Available Data

Aditya P. Mohanty Mailing Address

Above is the net worth, insider trading, and ownership report for Aditya P. Mohanty. You might contact Aditya P. Mohanty via mailing address: 1010 Atlantic Avenue, Suite 102, Alameda Ca 94501.

Discussions on Aditya P. Mohanty

No discussions yet.